Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Cellectis S.A. (CLLS) had Stock-Based Compensation of $6.11M for the most recently reported fiscal year, ending 2025-12-31.
| Income Statement Financials | |
$79.59M |
|
$-67.59M |
|
-- |
|
$79.59M |
|
$112.67M |
|
$-33.08M |
|
$-34.94M |
|
$-68.02M |
|
$-68.02M |
|
$-67.59M |
|
$-67.59M |
|
$-67.59M |
|
$-67.59M |
|
$-33.08M |
|
$-13.02M |
|
100.28M |
|
100.28M |
|
$-0.67 |
|
$-0.67 |
|
| Balance Sheet Financials | |
$236.24M |
|
$38.79M |
|
$88.48M |
|
$324.72M |
|
$145.75M |
|
$74.01M |
|
$103.07M |
|
$248.82M |
|
$75.90M |
|
$75.37M |
|
$75.90M |
|
72.34M |
|
| Cash Flow Statement Financials | |
$-39.40M |
|
$-29.48M |
|
$-16.76M |
|
$143.25M |
|
$61.53M |
|
$-81.72M |
|
|
Stock-Based Compensation |
$6.11M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.62 |
|
-- |
|
-- |
|
0.49 |
|
1.11 |
|
100.00% |
|
-41.56% |
|
-41.56% |
|
-16.35% |
|
-85.46% |
|
-84.92% |
|
$-41.76M |
|
-- |
|
-- |
|
-- |
|
0.25 |
|
-- |
|
3.59 |
|
101.80 |
|
-89.05% |
|
-89.69% |
|
-20.82% |
|
-45.09% |
|
$1.05 |
|
$-0.42 |
|
$-0.39 |
|